Melarth 5 mg tablete za žvakanje
| Name | Melarth 5 mg tablete za žvakanje |
|---|---|
| Marketing Authorisation Number | HR-H-871454299 |
| Active Substance | montelukastnatrij |
| Composition | jedna tableta za žvakanje sadrži 5 mg montelukasta (u obliku montelukastnatrija) |
| Pharmaceutical Form | tableta za žvakanje |
| Manufacturer | Pliva Hrvatska d.o.o., Zagreb, Hrvatska Teva Operations Poland Sp. z o.o., Krakow, Poljska |
| Marketing Authorisation Holder | Pliva Hrvatska d.o.o., Prilaz baruna Filipovića 25, Zagreb, Hrvatska |
| Marketing Authorisation Date | 21.11.2016 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/15-02/365 |
| Registration Number | 381-12-01/70-16-06 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | R03DC03 |
| Marketing status | Marketed |
| Shortage status | No shortage |
| SmPC | download |
| PL | download |
